A Phase 1b/2 Study of Enzalutamide Plus CC-115 in Men with Castration-Resistant Prostate Cancer (CRPC); Sponsor ¿ Memorial Sloan Kettering Cancer Center
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
The Prostate Cancer Clinical Trials Consortium
Start Date
May 21, 2018
End Date
December 31, 2021
Administered By
Duke Cancer Institute
Awarded By
The Prostate Cancer Clinical Trials Consortium
Start Date
May 21, 2018
End Date
December 31, 2021